InnoCare Pharma Limited (INCPF) Financials
INCPF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.7 billion | 474.7 million |
| March 31, 2026 | 1.5 billion | 435.2 million |
| Dec. 31, 2025 | 1.5 billion | 398.3 million |
| Sept. 30, 2025 | 1.3 billion | 399.5 million |
INCPF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 11.5 million | ? |
| March 31, 2026 | -599730 | ? |
| Dec. 31, 2025 | 25.3 million | ? |
| Sept. 30, 2025 | -2.1 million | ? |
INCPF Net Income
No data available :(
INCPF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.2 billion | 144.5 million | 1.7 million |
| March 31, 2026 | 1.0 billion | 182.5 million | 2.5 million |
| Dec. 31, 2025 | 1.0 billion | 182.4 million | 2.7 million |
| Sept. 30, 2025 | 985.7 million | 186.1 million | 2.2 million |
INCPF Shares Outstanding
INCPF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2.9 million | - | 29.3 million | - |
| March 31, 2026 | 2.9 million | 32.8 million | 23.4 million | - |
| Dec. 31, 2025 | 4.5 million | 36.0 million | 33.6 million | - |
| Sept. 30, 2025 | 2.0 million | 31.8 million | 26.4 million | - |
INCPF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 89.2 million | 11.6 million |
| March 31, 2026 | 75.7 million | 9.0 million |
| Dec. 31, 2025 | 177.4 million | 12.8 million |
| Sept. 30, 2025 | 53.9 million | 6.8 million |
INCPF
Price: $1.60
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.06 USD
P/E Ratio: 25.83
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.8 billion